Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units
NCT ID: NCT02840500
Last Updated: 2018-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2016-06-27
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is insufficient clinical information on the quality of life of cancer patients with breakthrough pain treated in palliative care units according to routine clinical practice. For this reason we consider it is appropriate to prospectively evaluate the quality of life of cancer patients with cancer breakthrough pain treated in palliative care units as well as the characteristics of these patients.
This post-authorization observational study will assess the quality of life of patients with breakthrough cancer pain treated in Palliative Care Units in Spanish hospitals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
NCT02836379
Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)
NCT03435120
Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer
NCT03837132
Integration of Palliative Care in an Oncology and Hematology Unit
NCT04089306
Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer: a Randomised Controlled Trial.
NCT01865396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breakthrough Cancer Pain
No intervention (Non-interventional study)
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with advanced cancer
* Patients attended in Palliative Care Units
* Life expectancy\> 3 months
* Written informed consent
* Patients with baseline controlled cancer pain with opioids who are diagnosed of breakthrough cancer pain by Davies algorithm
Exclusion Criteria
* Patients with evidence of opioid addiction or history of drug or alcohol abuse
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Angelini Farmacéutica
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Albert Tuca, MD
Role: STUDY_DIRECTOR
Hospital Clinic de Barcelona, Palliative Care Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Mollet
Mollet del Vallès, Barcelona, Spain
Hospital Sant Joan de Deu
Palma, Illes Baleares, Spain
Hospital Clínic
Barcelona, , Spain
Hospital Virgen de las Nieves
Granada, , Spain
Hospital Arnau de Vilanova
Lleida, , Spain
Hospital Gregorio Marañón
Madrid, , Spain
Fundación Jiménez Díaz
Madrid, , Spain
Complejo Hospitalario de Ourense
Ourense, , Spain
Hospital Virgen del Rocío
Seville, , Spain
Hospital Virgen de la Salud
Toledo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rodriguez AT, Viejo MN, Maradey P, Canal-Sotelo J, Mancilla PG, Rivero SG, Casillas IR, Abian MH, Bermudo CL. Low-dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain in palliative care. Future Oncol. 2022 May;18(14):1717-1731. doi: 10.2217/fon-2021-1639. Epub 2022 Feb 9.
Tuca Rodriguez A, Nunez Viejo M, Maradey P, Canal-Sotelo J, Guardia Mancilla P, Gutierrez Rivero S, Raja Casillas I, Herrera Abian M, Lopez Bermudo C. Impact of individualized management of breakthrough cancer pain on quality of life in advanced cancer patients: CAVIDIOPAL study. Support Care Cancer. 2021 Aug;29(8):4799-4807. doi: 10.1007/s00520-021-06006-1. Epub 2021 Feb 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANG-OPI-2016-01 (CAVIDIOPAL)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.